, J a p a n T h e r e n a l handlings o f oxypurinol a n d oxypurines by normal subjects after intake o f allopurinol w e r e investigated b y studies o n the influences o f uricosuric agents (probenecid a n d benzbromarone) a n d pyrazinamide. Pyrazinamide decreased t h e fractional clearance o f oxypurinol, hypoxanthine a n d xanthine 0.46-, 0.52-a n d 0.40-fold, respectively. Probenecid increased t h e fractional clearance o f oxypurinol 1.8-fold, decreased t h a t o f xanthine 0.61-fold and d i d n o t a f f e c t that of hypoxanthine. Benzbromarone increased t h e fractional clearance o f oxypurinol 2.17-fold b u t d i d n o t affect those o f hypoxanthine and xanthine. T h e s e results suggest t h a t oxypurinol i s reabsorbed a t least a t a postsecretory s i t e o f t h e renal tubules, t h a t t h e m a i n renal transport o f xanthine i s secretory w h e n conversion o f oxypurines t o u r i c acid i s decreased a n d t h a t the m a i n renal transport o f hypoxanthine t h a t i s n o t affected by these three agents may o c c u r w h e n conversion o f oxypurines t o uric acid i s decreased.
T h e r e n a l handlings o f oxypurinol a n d oxypurines by normal subjects after intake o f allopurinol w e r e investigated b y studies o n the influences o f uricosuric agents (probenecid a n d benzbromarone) a n d pyrazinamide. Pyrazinamide decreased t h e fractional clearance o f oxypurinol, hypoxanthine a n d xanthine 0.46-, 0.52-a n d 0.40-fold, respectively. Probenecid increased t h e fractional clearance o f oxypurinol 1.8-fold, decreased t h a t o f xanthine 0.61-fold and d i d n o t a f f e c t that of hypoxanthine. Benzbromarone increased t h e fractional clearance o f oxypurinol 2.17-fold b u t d i d n o t affect those o f hypoxanthine and xanthine. T h e s e results suggest t h a t oxypurinol i s reabsorbed a t least a t a postsecretory s i t e o f t h e renal tubules, t h a t t h e m a i n renal transport o f xanthine i s secretory w h e n conversion o f oxypurines t o u r i c acid i s decreased a n d t h a t the m a i n renal transport o f hypoxanthine t h a t i s n o t affected by these three agents may o c c u r w h e n conversion o f oxypurines t o uric acid i s decreased.
MODULATION OF DIPHTHAMIDE SYNTHESIS BY METHYLTHIOAOENOSINE. Hisashi Yamanaka* and
Institute of Scripps Clinic. USA Exogenous addition of methylthioadenosine (MeSAdo) inhibits proliferation of cells which are deficient in MeSAdo phosphorylase. A series of evidences has shown that the target of toxic mechanism of MeSAdo is not totally dependent on polyamine synthesis. Eukaryotic cells contain unique modified amino acid in elongation factor 2 (EF-2). designated as diphthamide. This residue is the specific target of mono(ADP-ribosy1)ation catalyzed by diphtheria toxin (DT) or Pseudomonous toxin.
The structure of diphthamide is 2-[3-carboxyamido-3-( t r l m e t h y l a m o n i o ) p r o p y l ] h i s t i d i n e , and the first reaction to modify histidine involves the transfer of an aminocarboxypropyl group from S-adenosylmethionine. MeSAdo should be the nucleoside product of this reaction. By these reasons. we have analyzed the effect of MeSAdo on the biosynthesis of diphthamide. A mutant cell line H3 which is deficient in MeSAdo phosphorylase and resistant to MeSAdo, has been isolated from murine lymphoma cell line R1.l. for the study. As measured by susceptibility to DT induced ADP-ribosylation, MeSAdo inhibits the formation of diphthamide in a dose dependent manner. In addition. MeSAdo substantially protected H3 cells from the lethal effect of DT. These results suggest that the modulation of diphthamide synthesis can be. at least a part of. the mechanism of MeSAdo toxicity toward eukaryotic cells. Poly(ADP-ribose) polymerase (ADPRP) is highly activated by DNA with strand breaks and transfer poly (ADP-ribose)chains out0 nuclear proteins. Poly (ADP-ribosyl )action rapidly consumes cellular NAD and leads cells to die. This reaction has been implied to be involved in the deoxyadenosine toxicity toward resting human lymphocytes, and could be an important mechanism in tne toxicity of all DNA-damaging agents. To analyze the characteristics of ADPRP. we have utilized human autoantibodies to ADPRP which we have identified in the sera of rheumatic patients. cDNA clones encoding ADPRP were isolated from human libraries and used in these studies. The results of these studies indicate that ADPRP is an'abundant nuclear enzyme. Eukaryotic cells synthesize ADPRP throughout S-phase, and keep the cellular AOPRP level constantly in proportion to the amount of DNA.
CHARACTERIZATION OF POLY(ADP-RIBOSE
Interestingly more than 99% of ADPRP is present in cells as inactive form. These data may suggest the importance of ADPRP as a structural protein in chromatin conformation. In addition. these results are consistent with the hypothesis of "suicide mechanism" of ADPRP. Eukaryotic cells have approximately 100-fold more enzyme than that is required for the regular cell growth. and keep it for an emergency event. When cellular DNA is severely damaged. ADPRP is activated and eliminates the cell. This mechanism could be applicable to the toxicity of any DNA damaging agents, including many purine and pyrimidine analogs. FERASE (ATase) 182 TAKASHI YAMAOKA, FUMIKO KAGITA, HIROKO YOSHIKAWA, MITSUO ITAKURA, AND KAMEJIRO YAMASHITA University of Tsukuba, Institute of Clinical Medicine, Tsukuba-shi, Ibaraki 305, JAPAN Purification of mammalian ATase is essential for the understanding of the regulation of de novo purine synthesis in mammals. The basic properties of rat liver ATase after step 4 of p~trification methods described below includes a) feedback inhibition by adenosine or guanosine mono-, di-and tri-phosphates, with the decreasing order of magnitude, b) Inhibition by 1.10-orthophenanthroline as a ~e * chelator, but not by 1,7-metaphenanthroline, and c) Inactivation by exposure to oxygen with a half life of 15 min at 37'C with the stable activity under argon. In this study ogygen inactivation of ATase was overcome by the use of oxygen-free buffer and 1lPLC methods. The purification procedures include the following 8 steps. 1. 55,000xg supernatant of rat liver homogenate, 2. Heat treatment to 56-C, 3. Acid precipitation to pH 5.1, 4. Ammonium sulfate fractionation between 30 and 55%, 5. Gel filtration by Toyopearl IIW55F, 6. DEAE-5PW HPLC column, 7. llydroxyapatite HPLC column, 8. SDS polyacrylarnide gel and electroelution. After step 7, ATase was purified to 958-fold with 4.1% recovery. After step 8, ATase was finally purified to homogeneity proved by a single protein band with silver stain. The monomer size of ATase was 62K on SDS polyacrylamide gel. The amount of ATase in rat liver is estimated as about 10 jlg/g liver. The methods of purification of mammalian ATase open the research direction to molecular cloning and monoclonal antibody production. 
PURIFICATION OF RAT LIVER AMIDOPHOSPHORIBOSYLTRANS-

R a b b i t h e a r t c o n t a i n~t w o c y t o s o l i c 5 ' -n u c l e o t i d a s e s ,
termed N-I and 1 1 , which can be separated using phosphocellulose chromatography.
N-I prefers AMP over IMP a s a substrate, in contrast to N-I1 whlch prefers IMP over AMP.
N-I1 closely resembles the soluble enzyme found in heart and liver of chicken and rat with respect to substrate specificity (Itoh and coworkers. Comp. Biochem. Biophys. 8 1 0 , 159-163 (1985) ; Biochim. Biophys. Acta 8 5 7 , 4 0 2 -4 1 0 (1981); Biochem. J.. 235. 847-851 (1986); and Nalto. Biochim. BiOphys. Acta 4 3 8 . 159-168 (1916) ). N-I has been purified approximately 1000-fold to a specific activlty of 9 0 umol/mg protein/min. The enzyme is strongly activated by A D P ; it is not activated by ATP. Gel filtration indicates a molecular weight f o r N-I of about 255,000. At low [AMP] . the activlty of N-I is stimulated by a regulatory protein (R) in the presence of ATP. R was also purified to homogeneity.
Gel electrophoresis in the presence of sodium dodecyl sulfate shows a subunit molecular weight for R of about 25,000. N-I is most likely the enzyme responsible for the release of adenosine from AMP under conditions of hypoxia or Increased work load.
PROLIFERATIVE EFFECT OF INSULIN BY SELECTIVE GENE EXPRESSION IN PURINE METABOLISM IN RAT HEPATOCYTES
184 HIROKO YOSHIKAWA, MASAMI SATO, TAKASIII YAMAOKA, MITSUO ITAKURA, AND KAMEJIRO YAMASHITA University of Tsukuba, Institute of Clinical Medicine, Tsukuba-shi, Ibaraki 305, JAPAN To study the mechanism of gene expression during cell proliferation, the effect of insulin as a growth factor on purine metabolism was studied in primary cultued rat hepatocytes. Hepatocytes were prepared by the collagenase perfusion methods of Berry and Friend from seven-week-old male Wistar rats. After the first plating culture for 4 hours, hepatocytes were cultured in Williams E medium without fetal calf serum or insulin for 20 hours. Then insulin was administered. Both the rates of DNA and de nove purine synthesis, assayed respectively by HI thymidine and [14~]formate incorporation, increased dose-and time-dependently to the maximum of 260 and 250%. respectively, with the same range of insulin concentrations between 10-7 and M at 24 and 8 hours. Insulin at 10-7 M at 8 hours increased the specific activities of amidophosphoribosyltransferase, hypoxanthine guanine p h o s p h o r i b o s y l t r a n s f e r a s e and adenine phosphoribosyltransfernse, respectively, to 180, 130 and 200%, whereas that of xanthine oxydase remained unchanged at 80%. The selective increases in the specific activities of anabolic enzymes of purine metabolic pathway were due to the induction of enzyme proteins shown by increased Vmax and unchanged Km and by the dissappearance of the increases by Actinomycin D or cycloheximide. It is concluded that the proliferative effect of insulin, associated with the increased rate of purine synthesis, is a result of selective gene expression of anabolic enzymes.
